Renaissance Technologies - TAYSHA GENE THERAPIES INC ownership

TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 1 filers reported holding TAYSHA GENE THERAPIES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TAYSHA GENE THERAPIES INC
ValueSharesWeighting
Q3 2023$1,890
+1177.0%
598,000
+166.5%
0.00%
Q2 2023$148
-25.6%
224,400
-10.1%
0.00%
Q1 2023$199
-83.1%
249,600
-52.0%
0.00%
-100.0%
Q4 2022$1,175
-99.9%
519,800
+24.2%
0.00%
+100.0%
Q3 2022$808,000
-58.5%
418,500
-20.1%
0.00%
-50.0%
Q2 2022$1,948,000
+19.3%
523,600
+109.0%
0.00%0.0%
Q1 2022$1,633,000250,5000.00%
Other shareholders
TAYSHA GENE THERAPIES INC shareholders Q4 2023
NameSharesValueWeighting ↓
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 1,391,190$29,493,00022.62%
Octagon Capital Advisors LP 320,440$6,793,0001.41%
Artal Group S.A. 1,040,882$22,067,0000.45%
Alphabet Inc. 640,882$13,587,0000.28%
Nantahala Capital Management 432,072$9,160,0000.26%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 500,000$10,600,0000.22%
TimesSquare Capital Management, LLC 683,400$14,488,0000.12%
Perceptive Advisors 640,880$13,586,0000.09%
Virtus ETF Advisers LLC 8,697$184,0000.08%
Granite Point Capital Management, L.P. 50,000$1,060,0000.04%
View complete list of TAYSHA GENE THERAPIES INC shareholders